INHALED ARGON FOR TREATING A PATIENT SUFFERING FROM CARDIOVASCULAR DISEASE
The invention concerns a use of argon gas administered by inhalation in order to directly protect or preserve haemodynamics and to prevent cardiovascular failure by controlling the blood flow, blood pressure and blood diffusion throughout the body of a human patient suffering from cardiovascular disease requiring heart or vascular surgery, in particular an aneurysm of the aorta, a myocardial ischaemia, a severe heart failure or a cardiopathy requiring a surgical operation. The argon is preferably mixed with oxygen..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 16. Nov. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
FARJOT GÉRALDINE [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-11-16, Last update posted on www.tib.eu: 2023-12-07, Last updated: 2023-12-15 |
|---|
| Patentnummer: |
US2023364130 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA018655416 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA018655416 | ||
| 003 | DE-627 | ||
| 005 | 20231215094657.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231201s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA018655416 | ||
| 035 | |a (EPA)US2023364130 | ||
| 035 | |a (EPA)74125362 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a FARJOT GÉRALDINE |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a INHALED ARGON FOR TREATING A PATIENT SUFFERING FROM CARDIOVASCULAR DISEASE |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-11-16, Last update posted on www.tib.eu: 2023-12-07, Last updated: 2023-12-15 | ||
| 520 | |a The invention concerns a use of argon gas administered by inhalation in order to directly protect or preserve haemodynamics and to prevent cardiovascular failure by controlling the blood flow, blood pressure and blood diffusion throughout the body of a human patient suffering from cardiovascular disease requiring heart or vascular surgery, in particular an aneurysm of the aorta, a myocardial ischaemia, a severe heart failure or a cardiopathy requiring a surgical operation. The argon is preferably mixed with oxygen. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a BILLOET CATHERINE |4 aut | |
| 700 | 0 | |a CHALOPIN MATTHIEU |4 aut | |
| 700 | 0 | |a DE ROUX QUENTIN |4 aut | |
| 700 | 0 | |a TISSIER RENAUD |4 aut | |
| 700 | 0 | |a MONGARDON NICOLAS |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 16. Nov. |
| 773 | 1 | 8 | |g year:2023 |g day:16 |g month:11 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/74125362/publication/US2023364130A1?q=US2023364130 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 16 |c 11 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 16 |c 11 | ||